Cover Image
市場調查報告書

分流動脈瘤治療的全球市場:2016年∼2020年

Global Flow Diversion Aneurysm Treatment Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 366013
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
分流動脈瘤治療的全球市場:2016年∼2020年 Global Flow Diversion Aneurysm Treatment Market 2016-2020
出版日期: 2016年08月03日 內容資訊: 英文 72 Pages
簡介

分流動脈瘤治療市場受到腦動脈瘤的增加,微創血管內手術的需求增加,技術的進步等要素推動。全球分流動脈瘤治療市場在2016年∼2020年這段期間,預測將以年複合成長率(CAGR)14.55%的速度成長。

本報告提供全球分流動脈瘤治療市場相關調查分析,提供您市場概要,各市場區隔考察,各地區考察,推動市場的要素,主要企業等概括性分析、彙整資料。

第1章 摘要整理

第2章 報告的範圍

第3章 顱內動脈瘤治療的發展

第4章 市場調查的方法

  • 調查方法
  • 經濟指標

第5章 簡介

第6章 市場的狀況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 分流的進行中臨床試驗與核准適用

第8章 血管內動脈瘤治療的進步

第9章 分流動脈瘤治療的全球市場:各地區

  • 南北美洲
  • 歐洲/中東/非洲
  • 亞太地區

第10章 購買標準

第11章 分流動脈瘤治療的全球市場:促進要素

  • 腦功能障礙造成腦動脈瘤的增加
  • 外科醫生的引進增加
  • 微創血管內手術的需求增加
  • 意識的提升

第12章 促進要素的影響

第13章 分流動脈瘤治療的全球市場:課題

第14章 促進要素與課題的影響

第15章 分流動脈瘤治療的全球市場:趨勢

  • 核准和臨床實驗藥的銷售
  • 進行中的臨床試驗
  • 新加入廠商者的巨大市場潛力
  • 顱內支架術的需求增加

第16章 供應商狀況

第17章 主要供應商分析

第18章 附錄

第19章 Technavio的其他的報告

目錄
Product Code: IRTNTR10067

About Flow Diversion Aneurysm Treatment

The global flow diversion aneurysm treatment market is driven by several factors that include the increase in the incidence of brain aneurysm, increase in demand for minimally invasive endovascular surgeries, and advances in technology. However, challenges such as risk of complications in cerebrovascular/neurovascular procedures, stringent regulations for the approval of devices, the high cost of flow diversion aneurysm treatment, and the increase in competition among vendors restrain the market growth.

Technavio's analysts forecast the global flow diversion aneurysm treatment market to grow at a CAGR of 14.55% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global flow diversion aneurysm treatment market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of flow diversion aneurysm devices to hospitals and ambulatory surgical centers (ASCs).

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Flow Diversion Aneurysm Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Balt Extrusion
  • Medtronic
  • MicroVention
  • Stryker

Other Prominent Vendors

  • Acandis
  • InspireMD
  • Phenox

Market driver

  • Increase in instances of brain aneurysm caused by cerebral disorders
  • For a full, detailed list, view our report

Market challenge

  • Complications associated with cerebrovascular/neurovascular procedures
  • For a full, detailed list, view our report

Market trend

  • Product approvals and tentative investigational product launches
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Evolution of treatment for intracranial aneurysm

  • Evolution of treatment for intracranial aneurysm: From clipping to flow diverters

PART 04: Market research methodology

  • Research methodology
  • Economic indicators

PART 05: Introduction

  • Key market highlights
  • Flow diversion devices
  • Regulatory environment

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Ongoing clinical trials and approved indications for flow diverters

PART 08: Evolution of endovascular aneurysm treatment

  • Past
  • Present

PART 09: Geographical segmentation

  • Flow diversion aneurysm treatment market in Americas
  • Market size and forecast
  • Flow diversion aneurysm treatment market in EMEA
  • Market size and forecast
  • Flow diversion aneurysm treatment market in APAC
  • Market size and forecast

PART 10: Buying criteria

PART 11: Market drivers

  • Increase in instances of brain aneurysm caused by cerebral disorders
  • Growing adoption by surgeons
  • Increase in demand for minimally invasive endovascular surgeries
  • Rise in awareness

PART 12: Impact of drivers

PART 13: Market challenges

  • Complications associated with cerebrovascular/neurovascular procedures
  • Threat of alternative treatments
  • Inadequate clinical evidence
  • Manufacturing hurdles and delay in product launches due to stringent regulatory environment

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Product approvals and tentative investigational product launches
  • Ongoing clinical trials
  • Huge market potential for new entrants
  • Rise in demand for intracranial stenting procedures

PART 16: Vendor landscape

  • Competitive scenario
  • Product matrix

PART 17: Key vendor analysis

  • Balt Extrusion
  • Medtronic
  • MicroVention
  • Stryker
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Evolution of treatments for intracranial aneurysm
  • Exhibit 03: Global neurointerventional devices market 2015
  • Exhibit 04: Top vendors in global neurosurgery devices market 2015
  • Exhibit 05: Individuals showing symptoms indicative of unruptured aneurysm 2014
  • Exhibit 06: Comparison of different types of treatments for intracranial aneurysm
  • Exhibit 07: FDA classification on medical device by type of class
  • Exhibit 08: Global flow diversions aneurysm treatment market analysis: Developed and emerging markets
  • Exhibit 09: Global flow diversion aneurysm treatment market 2015-2020 ($ millions)
  • Exhibit 10: Opportunity analysis of global flow diversion aneurysm treatment market
  • Exhibit 11: Five forces analysis
  • Exhibit 12: Major clinical trials for endovascular aneurysm and flow diversion treatment
  • Exhibit 13: Approved indications for flow diverters in US and Europe
  • Exhibit 14: Volume units across all neurovascular coiling procedures 2014
  • Exhibit 15: Vendors and products available
  • Exhibit 16: Number of flow diversion procedures performed in 2013
  • Exhibit 17: Number of flow diversion procedures performed in 2014
  • Exhibit 18: Global flow diversion aneurysm treatment market: Geographical presence
  • Exhibit 19: Global flow diversion aneurysm treatment market: Geography lifecycle analysis 2015
  • Exhibit 20: Global flow diversion aneurysm treatment market by geography 2015 and 2020
  • Exhibit 21: Global flow diversion aneurysm treatment market by geography 2015
  • Exhibit 22: Flow diversion aneurysm treatment market in Americas 2015-2020 ($ millions)
  • Exhibit 23: Flow diversion aneurysm treatment market in EMEA 2015-2020 ($ millions)
  • Exhibit 24: Flow diversion aneurysm treatment market in APAC 2015-2020 ($ millions)
  • Exhibit 25: Flow diversion aneurysm treatment market by geography 2015-2020 ($ millions)
  • Exhibit 26: Flow diversion aneurysm treatment market by geography 2015-2020
  • Exhibit 27: Key buying criteria for flow diversion aneurysm treatment
  • Exhibit 28: Impact of drivers
  • Exhibit 29: Reported cases of rupture at later stage in large aneurysm (17-35 mm)
  • Exhibit 30: Impact of drivers and challenges
  • Exhibit 31: Vendors and products available in market
  • Exhibit 32: Product matrix
  • Exhibit 33: Balt Extrusion: Distributors
  • Exhibit 34: Balt Extrusion: Metric analysis
  • Exhibit 35: Medtronic: Product segmentation
  • Exhibit 36: Medtronic: Restorative therapies group by revenue 2013-2015 ($ billions)
  • Exhibit 37: Medtronic: Metric analysis
  • Exhibit 38: MicroVention: Distributors
  • Exhibit 39: MicroVention: Metric analysis
  • Exhibit 40: Stryker: Product segmentation
  • Exhibit 41: Stryker: Neurotechnology and spine segment by revenue 2013-2015 ($ billions)
  • Exhibit 42: Stryker: Metric analysis
Back to Top